Skip to main content
Professional background
Biography image

Faith L.Charles

PartnerCo-Chair, Public Companies GroupChair, Life Sciences
New York

O 212.908.3905

Faith L.Charles

Partner
Co-Chair, Public Companies GroupChair, Life Sciences
New York

O 212.908.3905

Faith, a corporate transactions and securities partner, leads the firm’s Life Sciences practice, and is one of few women who serve as trusted advisors and outside counsel to dozens of public and emerging life sciences companies, providing valuable insights into capital markets, corporate governance and strategic collaborations. With over 30 years of industry experience, Faith has cultivated a deep understanding of how to launch and build a successful life sciences business. She also counsels companies in the health care information technology, cannabis, energy, retail and consumer product sectors.

Faith skillfully leads, manages and negotiates a wide range of complex and transformative private and public financing transactions, acquisitions and dispositions, and strategic collaborations, nationally and internationally. She has completed more than 250 securities offerings, with gross proceeds totaling billions of dollars.

The Deal Top Women in Dealmaking - Faith Charles

Named a BTI All-Star for client service excellence

Focus Areas

  • Recommended by LMG Life Sciences, Finance & Transactional, 2013-2016, 2024
  • Named one of The Deal’s Top Women in Dealmaking, M&A and Private Equity, 2023
  • Named a Notable Women in Law by Crain’s New York Business, 2020
  • Graduate, Women in Bio’s First Boardroom Ready Program, George Washington University’s Executive Education School
  • BTI Client Service All-Star 

Professional Associations

  • Board Member; Member, Nomination & Corporate Governance Committee; Chair, Compensation Committee – Conduit Pharmaceuticals, 2022-present
  • Member, National Board of Directors – Women in Bio; founder of New York Chapter
  • Member, Board of Directors – Red Door Community, New York City
  • Founder and Co-Leader – BioDirector, New York Chapter
  • Member, Life Sciences Council – Springboard Enterprises
  • Member, Executive Committee, Life Sciences Sector – The Licensing Executive Society (USA and Canada)
  • Board Chair; Member, Nominating Committee – CNS Pharmaceuticals, Inc. (Nasdaq: CNSP), 2022-present
  • Board Member; Member, Audit Committee – Avenue Therapeutics, Inc. (Nasdaq: ATXI), 2022-present
  • Board Member; Chair, Nomination & Corporate Governance Committee; Member, Compensation Committee – Abeona Therapeutics (Nasdaq: ABEO), 2021-present
  • Board Member; Member, Audit Committee; Chair, Compensation Committee – Board of Directors, Entera Bio Ltd. (Nasdaq: ENTX), 2018-2021
  • Member – CHIEF, New York City 2022-2023
  • Board Member – Amydis, Inc., 2019-2022
  • Board Member; Member, Audit Committee; Chair, Compensation Committee  – Entera Bio Ltd., 2018-2021
  • Board Member – Sandstone Diagnostics, Inc., 2018-2021

Education

  • George Washington University Law Center, 1986
  • Barnard College, B.A., 1983,
    cum laude

Bar Admissions

  • New York

Languages

  • Hebrew